Featured Articles

  • Orchestrating cell and gene therapies

    Tuesday, March 25, 2025
    An effective orchestration platform is now essential in optimizing processes, fostering collaboration, and ensuring the safe and effective administration of CGTs. These orchestration platforms are crucial tools for approved treatment center... read more

  • Considerations for successful scale-up and viral vector purification

    Wednesday, March 19, 2025
    To scale up a process, there are several important considerations, starting with the selection of a target batch size. However, process scale-up can encounter challenges. Here, several key considerations will be discussed, and specific ... read more

  • A new era in cancer care

    Thursday, March 13, 2025
    Immunotherapy has transformed the field of oncology by harnessing the immune system’s innate ability to mount targeted attacks on cancer cells. Building on this foundation, cell and gene therapies take immunotherapy to the next level by ... read more

  • Is CGT ready for prime time?

    Tuesday, March 11, 2025
    While challenges with commercial rollouts have been attributed to clinical site readiness, reimbursement coverage and accessibility, CGT drugs to date have predominantly targeted relatively small patient populations, effectively ... read more

  • A standardized approach to CGT quality management

    Wednesday, March 05, 2025
    This article describes the thought processes involved in defining control strategies across important areas including aseptic control, material control, process control, quality control and chain of custody control. We offer examples of how... read more

  • Written in the CARs

    Tuesday, February 25, 2025
    To quote Astronomers Without Borders, “Boundaries vanish when we look skyward.” In a perfect world, this same philosophy would guide global access to cell and gene therapies. read more

  • Within reach: Bringing cell and gene therapies to under-resourced regions

    Tuesday, February 18, 2025
    As multiple stakeholders come at the problem from different angles, sustainable global access pathways are beginning to align. From process efficiencies aimed at reining in costs to innovative manufacturing and go-to-market models, cell and... read more

  • Charting a path with biomarker discovery tools

    Tuesday, February 11, 2025
    Biomarkers have become indispensable in the creation and optimization of cutting-edge treatments. read more

  • The biggest challenges in cell and gene therapy

    Monday, February 03, 2025
    To benchmark the sector’s progress in the inaugural issue of Cell & Gene Therapy Review, we asked thought leaders a single question: What is the biggest challenge facing the CGT sector in 2025? read more

  • 2025 cell and gene challenges: Investment, technology and innovation

    Monday, February 03, 2025
    To benchmark the sector’s progress in the inaugural issue of Cell & Gene Therapy Review, we asked thought leaders a single question: What is the biggest challenge facing the CGT sector in 2025? read more

  • 2025 cell and gene challenges: Thoughts from our editorial board

    Monday, February 03, 2025
    To benchmark the sector’s progress in the inaugural issue of Cell & Gene Therapy Review, we asked thought leaders a single question: What is the biggest challenge facing the CGT sector in 2025? read more

  • 2025 cell and gene challenges: Scalability, supply chain and manufacturing

    Monday, February 03, 2025
    To benchmark the sector’s progress in the inaugural issue of Cell & Gene Therapy Review, we asked thought leaders a single question: What is the biggest challenge facing the CGT sector in 2025? read more
Page